Literature DB >> 25693053

Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.

Eszter Boros1, Peter Caravan.   

Abstract

Two structural isomers of the heptadentate chelator DO3Ala were synthesized, with carboxymethyl groups at either the 1,4- or 1,7-positions of the cyclen macrocycle. To interrogate the relaxivity under different rotatational dynamics regimes, the pendant primary amine was coupled to ibuprofen to enable binding to serum albumin. These chelators 6a and 6b form bis(aqua) ternary complexes with Gd(III) or Tb(III) as estimated from relaxivity measurements or luminescence lifetime measurements in water. The relaxivity of [Gd(6a)(H2O)2] and [Gd(6b)(H2O)2] was measured in the presence and absence of coordinating anions prevalent in vivo such as phosphate, lactate, and bicarbonate and compared with data attained for the q = 2 complex [Gd(DO3A)(H2O)2]. We found that relaxivity was reduced through formation of ternary complexes with lactate and bicarbonate, albeit to a lesser degree then the relaxivity of Gd(DO3A). In the presence of 100-fold excess phosphate, relaxivity was slightly increased and typical for q = 2 complexes of this size (8.3 mM(-1) s(-1) and 9.5 mM(-1) s(-1), respectively, at 37 °C, 60 MHz). Relaxivity for the complexes in the presence of HSA corresponded well to relaxivity obtained for complexes with reduced access for inner-sphere water (13.5 and 12.7 mM(-1) s(-1) at 37 °C, 60 MHz). Mean water residency time at 37 °C was determined using temperature-dependent (17)O-T2 measurements at 11.7 T and calculated to be (310)τM = 23 ± 1 ns for both structural isomers. Kinetic inertness under forcing conditions (pH 3, competing DTPA ligand) was found to be comparable to [Gd(DO3A)(H2O)]. Overall, we found that the replacement of one of the acetate arms of DO3A with an amino-propionate arm does not significantly alter the relaxometric and kinetic inertness properties of the corresponding Gd complexes; however, it does provide access to easily functionalizable q = 2 derivatives.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693053      PMCID: PMC4758459          DOI: 10.1021/ic503035f

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  36 in total

1.  Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.

Authors:  Zhaoda Zhang; Matthew T Greenfield; Marga Spiller; Thomas J McMurry; Randall B Lauffer; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-21       Impact factor: 15.336

2.  How to determine free Gd and free ligand in solution of Gd chelates. A technical note.

Authors:  Alessandro Barge; Giancarlo Cravotto; Eliana Gianolio; Franco Fedeli
Journal:  Contrast Media Mol Imaging       Date:  2006 Sep-Oct       Impact factor: 3.161

3.  Lower ligand denticity leading to improved thermodynamic and kinetic stability of the Gd3+ complex: the strange case of OBETA.

Authors:  Zsolt Baranyai; Mauro Botta; Marianna Fekete; Giovanni B Giovenzana; Roberto Negri; Lorenzo Tei; Carlos Platas-Iglesias
Journal:  Chemistry       Date:  2012-05-21       Impact factor: 5.236

4.  [Gd(CyPic3A)(H2O)2]-: a stable, bis(aquated) and high-relaxivity Gd(III) complex.

Authors:  Eric M Gale; Nathaniel Kenton; Peter Caravan
Journal:  Chem Commun (Camb)       Date:  2013-08-01       Impact factor: 6.222

5.  Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.

Authors:  Jakub Rudovský; Petr Cígler; Jan Kotek; Petr Hermann; Pavel Vojtísek; Ivan Lukes; Joop A Peters; Luce Vander Elst; Robert N Muller
Journal:  Chemistry       Date:  2005-04-08       Impact factor: 5.236

6.  pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation.

Authors:  M P Lowe; D Parker; O Reany; S Aime; M Botta; G Castellano; E Gianolio; R Pagliarin
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

7.  A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions.

Authors:  João Bruno Livramento; Angélique Sour; Alain Borel; André E Merbach; Eva Tóth
Journal:  Chemistry       Date:  2006-01-23       Impact factor: 5.236

8.  High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Authors:  Stéphane Dumas; Vincent Jacques; Wei-Chuan Sun; Jeffrey S Troughton; Joel T Welch; Jaclyn M Chasse; Heribert Schmitt-Willich; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

9.  Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates.

Authors:  John W Chen; Manel Querol Sans; Alexei Bogdanov; Ralph Weissleder
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

10.  Reaction of gadolinium chelates with endogenously available ions.

Authors:  M F Tweedle; J J Hagan; K Kumar; S Mantha; C A Chang
Journal:  Magn Reson Imaging       Date:  1991       Impact factor: 2.546

View more
  3 in total

1.  Intramolecular Hydrogen Bonding Restricts Gd-Aqua-Ligand Dynamics.

Authors:  Eszter Boros; Raja Srinivas; Hee-Kyung Kim; Arnold M Raitsimring; Andrei V Astashkin; Oleg G Poluektov; Jens Niklas; Andrew D Horning; Bruce Tidor; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2017-04-11       Impact factor: 15.336

Review 2.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

3.  Hydration number: crucial role in nuclear magnetic relaxivity of Gd(III) chelate-based nanoparticles.

Authors:  Rustem Zairov; Gulshat Khakimullina; Sergey Podyachev; Irek Nizameev; Georgy Safiullin; Rustem Amirov; Alberto Vomiero; Asiya Mustafina
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.